Skip to main content

Food Allergy News and Research

People With Food Allergies Can Get the COVID-19 Vaccine

Updates as of Dec. 13, 2021: We have updated this blog post to reflect the most recent recommendations from the Asthma and Allergy Foundation of America (AAFA) and the Centers for Disease Control and Prevention (CDC). As more information becomes available, we will continue to update our community. The COVID-19 vaccine is an important part of reducing the spread of the coronavirus , ending the pandemic, and protecting ourselves and other people. It can reduce your chance of severe COVID-19,...

The Flu Vaccine Is Safe for People With an Egg Allergy

It is safe for ALL people (6 months and older) with an egg allergy to get a flu vaccine every year. This is true no matter how severe your egg allergy was in the past. This includes people who have had anaphylaxis (a severe allergic reaction) to egg. Five organizations recommend that people get the flu vaccine every year, even if they have an egg allergy. These organizations are: Asthma and Allergy Foundation of America (AAFA) Centers for Disease Control and Prevention (CDC) American Academy...

New AAFA Research Aims to Improve Diagnosis and Treatment of Severe Allergic Reactions in Infants and Toddlers

Recognizing Severe Allergic Reactions in Infants and Toddlers Anaphylaxis is a severe allergic reaction that can be life-threatening if not treated quickly and properly. But the signs and symptoms can be hard to recognize, especially in infants and toddlers. One of the biggest challenges is that this age group is nonverbal. Infants cannot talk about their symptoms, so parents and doctors may not notice or identify the signs of an allergic reaction. Research also suggests infants and toddlers...

AAFA’s Medical Scientific Council Shares Statement on Early Pfizer-BioNTech COVID-19 Vaccine Safety Questions for People With Allergies

"Recent media reports of reactions to the new Pfizer/BioNTech COVID-19 vaccine, first out of the U.K. and now one report in the United States are stirring safety concerns for people with a history of serious allergies. It’s important to remember that we still don’t have the full details regarding the specifics of any of these reported reactions. Allergists, the Food and Drug Administration (FDA), and the Centers for Disease Control and Prevention (CDC) are all keeping an eye on these...

Why It's Important to Carry Epinephrine With You Everywhere You Go When You Have Food Allergies

The Asthma and Allergy Foundation of America (AAFA) and MedicAlert have teamed up to help you manage your child’s food allergies and prevent severe allergic reactions. (Kids With Food Allergies is a division of AAFA). We’re asking you to “ACT” to manage your child’s allergies: “A” means have an action plan for anaphylaxis. “C” reminds you to carry important medicines and have your child wear a medical ID to alert others of their condition. “T” calls for having a treatment plan that includes...

How an Action Plan Can Help You Treat Anaphylaxis

The Asthma and Allergy Foundation of America (AAFA) and MedicAlert have teamed up to help you manage your child’s food allergies and prevent severe allergic reactions. (Kids With Food Allergies is a division of AAFA). We’re asking you to “ACT” to manage your child’s allergies: “A” means have an action plan for anaphylaxis. “C” reminds you to carry important medicines and have your child wear a medical ID to alert others of their condition. “T” calls for having a treatment plan that includes...

Breaking News: FDA Approves Palforzia, a Ground-Breaking Peanut Allergy Oral Immunotherapy Treatment

On Jan. 31, 2020, the U.S. Food and Drug Administration (FDA) announced its approval of Aimmune Therapeutics’ peanut treatment, Palforzia, for children ages 4 to 17. This is big news for the food allergy community. Food allergies put a significant mental, social and financial burden on families. Until now, strict avoidance has been the only way to avoid allergic reactions. Palforzia may give many families managing peanut allergies more freedom and greater quality of life.

AAFA Brings Patient Voice to FDA Committee Review on Palforzia, Oral Immunotherapy Treatment for Peanut Allergy

On Sept. 13, 2019, the U.S. Food and Drug Administration’s (FDA) Allergenic Products Advisory Committee recommended the approval of Aimmune Therapeutics’ peanut treatment, Palforzia. If approved, Palforzia would be ground-breaking for the future of food allergy treatments. What Is Palforzia? Palforzia, also known as AR101, is a type of oral immunotherapy (OIT) for peanut allergy. If approved, it would be the first FDA-approved treatment for peanut allergy. Currently, some allergists already...

Asthma and Allergy Foundation of America Responds to Premature ICER Review of New Peanut Allergy Treatments

The Asthma and Allergy Foundation of America (AAFA) addresses concerns regarding the Final Evidence Report assessing the clinical effectiveness and value of treatments for peanut allergy released by the Institute for Clinical and Economic Review (ICER) on July 10, 2019. ICER’s report may cause concern for the allergy community that the findings will restrict access to new treatments for peanut allergy.

FDA Extends Expiration Dates of All Lots of EpiPens® and Authorized Generic

As supply interruptions and shortages of epinephrine auto-injectors continue, the FDA has extended the expiration dates of all lots of EpiPen® (epinephrine injection, USP) 0.3 mg Auto-Injectors and its authorized generic version currently on the market in the U.S. after a review of stability data. Read more for the new expiration dates.

Help Others See Beyond Food Allergies During National Asthma and Allergy Awareness Month and Food Allergy Awareness Week

Each May since 1984, the Asthma and Allergy Foundation of America (AAFA) has declared May to be National Asthma and Allergy Awareness Month. This month is dedicated to teaching others about asthma and allergies to create more awareness and understanding. Kids With Food Allergies (KFA) is a division of AAFA. May 12-18, 2019, is also Food Allergy Awareness Week. During this week, we focus on spreading information about what it’s like to manage food allergies and raise awareness about anaphylaxis,

FDA Approves First Generic Competitor of EpiPen Epinephrine Auto-Injector

The U.S. Food and Drug Administration today approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those that are life-threatening (anaphylaxis), in adults and pediatric patients who weigh more than 33 pounds. Teva Pharmaceuticals USA gained approval to market its generic epinephrine auto-injector in 0.3 mg and 0.15 mg strengths.

Post
Kids With Food Allergies
A Division of the Asthma and Allergy Foundation of America
1235 South Clark Street Suite 305, Arlington, VA 22202
Phone: 1-800-7-ASTHMA (1.800.727.8462)
-->
×
×
×
×